References
1. Selenius JS, Martelius T, Pikkarainen S, Siitonen S, Mattila E, Pietikainen R, et al. Unexpectedly High Prevalence of Common Variable Immunodeficiency in Finland. Frontiers in immunology. 2017;8:1190.
2. Ameratunga R, Brewerton M, Slade C, Jordan A, Gillis D, Steele R, et al. Comparison of diagnostic criteria for common variable immunodeficiency disorder. Frontiers in immunology. 2014;5:415.
3. Bonilla FA, Barlan I, Chapel H, Costa-Carvalho BT, Cunningham-Rundles C, de la Morena MT, et al. International Consensus Document (ICON): Common Variable Immunodeficiency Disorders. The journal of allergy and clinical immunology In practice. 2016;4(1):38-59.
4. Seidel MG, Kindle G, Gathmann B, Quinti I, Buckland M, van Montfrans J, et al. The European Society for Immunodeficiencies (ESID) Registry Working Definitions for the Clinical Diagnosis of Inborn Errors of Immunity. The journal of allergy and clinical immunology In practice. 2019;7(6):1763-70.
5. Ho HE, Cunningham-Rundles C. Non-infectious Complications of Common Variable Immunodeficiency: Updated Clinical Spectrum, Sequelae, and Insights to Pathogenesis. Frontiers in immunology. 2020;11:149.
6. Resnick ES, Moshier EL, Godbold JH, Cunningham-Rundles C. Morbidity and mortality in common variable immune deficiency over 4 decades. Blood. 2012;119(7):1650-7.
7. Rizvi FS, Zainaldain H, Rafiemanesh H, Jamee M, Hossein-Khannazer N, Hamedifar H, et al. Autoimmunity in common variable immunodeficiency: a systematic review and meta-analysis. Expert review of clinical immunology. 2020;16(12):1227-35.
8. Agarwal S, Cunningham-Rundles C. Autoimmunity in common variable immunodeficiency. Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology. 2019;123(5):454-60.
9. Farmer JR, Ong MS, Barmettler S, Yonker LM, Fuleihan R, Sullivan KE, et al. Common Variable Immunodeficiency Non-Infectious Disease Endotypes Redefined Using Unbiased Network Clustering in Large Electronic Datasets. Frontiers in immunology. 2017;8:1740.
10. Milota T, Sumnik Z, Obermannova B, Kralickova P, Vondrak K, Klocperk A, et al. Negativity for Specific Autoantibodies in Patients with Type 1 Diabetes That Developed on a Background of Common Variable Immunodeficiency. International archives of allergy and immunology. 2015;168(3):197-204.
11. Quinti I, Pulvirenti F, Milito C, Granata G, Giovannetti G, La Marra F, et al. Hemolysis in patients with antibody deficiencies on immunoglobulin replacement treatment. Transfusion. 2015;55(5):1067-74.
12. Lamoureux J, Aubin E, Lemieux R. Autoantibodies purified from therapeutic preparations of intravenous immunoglobulins (IVIg) induce the formation of autoimmune complexes in normal human serum: a role in the in vivo mechanisms of action of IVIg? International immunology. 2004;16(7):929-36.
13. van der Molen RG, Hamann D, Jacobs JF, van der Meer A, de Jong J, Kramer C, et al. Anti-SSA antibodies are present in immunoglobulin preparations. Transfusion. 2015;55(4):832-7.
14. Pedersen OM, Aardal NP, Larssen TB, Varhaug JE, Myking O, Vik-Mo H. The value of ultrasonography in predicting autoimmune thyroid disease. Thyroid : official journal of the American Thyroid Association. 2000;10(3):251-9.
15. Sorgjerd EP, Thorsby PM, Torjesen PA, Skorpen F, Kvaloy K, Grill V. Presence of anti-GAD in a non-diabetic population of adults; time dynamics and clinical influence: results from the HUNT study. BMJ open diabetes research & care. 2015;3(1):e000076.
16. Amouzegar A, Gharibzadeh S, Kazemian E, Mehran L, Tohidi M, Azizi F. The Prevalence, Incidence and Natural Course of Positive Antithyroperoxidase Antibodies in a Population-Based Study: Tehran Thyroid Study. PloS one. 2017;12(1):e0169283.
17. Tipu HN, Ahmed D, Bashir MM, Asif N. Significance of Testing Anti-Thyroid Autoantibodies in Patients with Deranged Thyroid Profile. Journal of thyroid research. 2018;2018:9610497.
18. Ilonen J, Lempainen J, Veijola R. The heterogeneous pathogenesis of type 1 diabetes mellitus. Nature reviews Endocrinology. 2019;15(11):635-50.
19. Rydzewska M, Jaromin M, Pasierowska IE, Stozek K, Bossowski A. Role of the T and B lymphocytes in pathogenesis of autoimmune thyroid diseases. Thyroid research. 2018;11:2.
20. Taplin CE, Barker JM. Autoantibodies in type 1 diabetes. Autoimmunity. 2008;41(1):11-8.
21. Tomer Y, Huber A. The etiology of autoimmune thyroid disease: a story of genes and environment. Journal of autoimmunity. 2009;32(3-4):231-9.
22. Hameed S, Ellard S, Woodhead HJ, Neville KA, Walker JL, Craig ME, et al. Persistently autoantibody negative (PAN) type 1 diabetes mellitus in children. Pediatric diabetes. 2011;12(3 Pt 1):142-9.
23. Wang J, Miao D, Babu S, Yu J, Barker J, Klingensmith G, et al. Prevalence of autoantibody-negative diabetes is not rare at all ages and increases with older age and obesity. The Journal of clinical endocrinology and metabolism. 2007;92(1):88-92.
24. Rotondi M, de Martinis L, Coperchini F, Pignatti P, Pirali B, Ghilotti S, et al. Serum negative autoimmune thyroiditis displays a milder clinical picture compared with classic Hashimoto’s thyroiditis. European journal of endocrinology. 2014;171(1):31-6.